GridAI Technologies Corp. GRDX

Q2 FY2026 · ended Jun 30, 2026 · Revenue $85,876, +124.8% YoY · Filed Sep 18, 2026

GridAI Technologies Corp. (GRDX) files with the SEC under industry code 4931, Electric & Other Services Combined. In Q2 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $85,876 and a net loss of $13.0 million. As of Jun 30, 2026 it held $1.4 million in cash and investments and $1.8 million in total debt.

Revenue
$85,876
+124.8% vs prior quarter
Net income
$-13.04M
-279.2% vs prior quarter
Operating cash flow
$-1.50M
-2642.1% vs year-ago quarter
Free cash flow
—
EPS
$-2.01
-145.1% vs prior quarter
Dividend per share
None
Shares outstanding
7.13M
+49.6% vs year-ago quarter
Net cash
$-432,249
Q2 FY2026
Operating margin
-15262.4%
Q2 FY2026

Company profile

Industry
Electric & Other Services Combined (SIC 4931)
Listed as
GRDX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Boca Raton, FL
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1604191
Former names
Entero Therapeutics, Inc. (until Nov 19, 2025); First Wave BioPharma, Inc. (until May 16, 2024); AzurRx BioPharma, Inc. (until Sep 14, 2021); BioPharma d'Azur, Inc. (until Apr 2, 2014)

Other Electric & Other Services Combined companies

Key figures

Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.

Line
Q2 FY2026
Jun 30, 2026
Q1 FY2026
Mar 31, 2026
Revenue
$85,876
$38,208
Operating income
-$13.1M
-$3.6M
Net income
-$13.0M
-$3.4M
Diluted EPS
-$2.01
-$0.82
Operating cash flow
-$1.5M
-$1.8M
Total assets
$37.0M
$48.0M
Total liabilities
$18.3M
$20.5M
Stockholders' equity
$14.9M
$23.6M
Cash and investments
$1.4M
$385,542
Total debt
$1.8M
$2.5M

Recent SEC filings

Recent SEC filings
Form Description Filed Period
8-K Current report
Officer or director change
Oct 30, 2026 Oct 26, 2026
8-K Current report
Material agreement
Oct 28, 2026 Oct 22, 2026
8-K Current report
Material agreement, Unregistered share sale
Oct 28, 2026 Oct 22, 2026
8-K Current report
Officer or director change
Oct 23, 2026 Oct 19, 2026
8-K Current report
Material agreement
Oct 7, 2026 Oct 1, 2026
10-Q/A Amended quarterly report Sep 18, 2026 Jun 30, 2026

Source: SEC EDGAR filings. This is company-reported data, not investment advice.